The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Regulatory News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.00
Bid: 4.00
Ask: 6.00
Change: 0.00 (0.00%)
Spread: 2.00 (50.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 5.00
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Conditional disposal of interest-Investee Company

2 Aug 2016 12:08

RNS Number : 0087G
Braveheart Investment Group plc
02 August 2016
 

 

2 August 2016

Braveheart Investment Group plc

('Braveheart', the 'Company' or the 'Group')

 

Conditional disposal of interest in Investee Company

 

Further to the announcement on 29 July 2016, the board of Braveheart is pleased to announce that it has agreed terms to conditionally sell its 1.25 per cent. interest and the 3.75 per cent. interest held by Strathclyde Investment Fund ("SIF"), in which the Group has an 89.3 per cent. interest, in mLED Limited ("mLED") to a large US based technology company. The sale is conditional, inter alia, on the termination of certain employee and other contracts and on subsequent completion of the transaction (expected in early September, but by no later than early November). The cost of terminating these contracts will be offset against the sale proceeds.

The total net consideration to be paid to the Group is to be satisfied entirely in cash. It is estimated that the Group will receive a total net consideration of £381,000.

mLED provides ultra-high brightness microLED array technology for the fast growing markets of Near-To-Eye, Head-Up-Display, Wearables, Printing and Lithography. The company is a spin-out from the University of Strathclyde. At 31 March 2016, the net book value of the interest held by the Group was £96,000. Accordingly, the estimated total net consideration receivable will result in a profit to the Group of £285,000.

The proceeds of the sale of the mLED shares, as and when received, will increase the Group's cash reserves and will be used for investing in suitable opportunities in accordance with the Group's investment strategy and for working capital generally.

Given the outstanding conditions of the sale, there can be no certainty that the transaction will be completed. A further announcement will be made in due course.

Further information:

Braveheart Investment Group plc

Trevor Brown, CEO Tel: +44 1738 587555

 

Allenby Capital Limited (Nominated Adviser and Broker to Braveheart)

David Worlidge / James Thomas Tel: +44 20 3328 5656

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISEAFPAEEXKEFF
Date   Source Headline
5th Nov 20204:41 pmRNSSecond Price Monitoring Extn
5th Nov 20204:36 pmRNSPrice Monitoring Extension
4th Nov 20208:52 amRNSExercise of Warrants and Issue of Equity
3rd Nov 202011:06 amRNSSecond Price Monitoring Extn
3rd Nov 202011:00 amRNSPrice Monitoring Extension
2nd Nov 20202:06 pmRNSSecond Price Monitoring Extn
2nd Nov 20202:01 pmRNSPrice Monitoring Extension
29th Oct 20204:40 pmRNSSecond Price Monitoring Extn
29th Oct 20204:35 pmRNSPrice Monitoring Extension
29th Oct 20207:00 amRNSIssue of shares to certain directors and TVR
27th Oct 20202:05 pmRNSSecond Price Monitoring Extn
27th Oct 20202:00 pmRNSPrice Monitoring Extension
23rd Oct 20207:00 amRNSUpdate on Pharm2Farm’s COVID-19 mask project
19th Oct 20202:06 pmRNSSecond Price Monitoring Extn
19th Oct 20202:00 pmRNSPrice Monitoring Extension
19th Oct 202012:42 pmRNSFurther re. Conditional Sale of Pharm2Farm holding
19th Oct 202012:35 pmRNSPublication of Circular and Notice of GM
16th Oct 20207:00 amRNSFurther update re Paraytec Limited
8th Oct 20204:09 pmRNSUpdate on Pharm2Farm
5th Oct 202011:20 amRNSFurther update re Paraytec Limited
29th Sep 20204:40 pmRNSSecond Price Monitoring Extn
29th Sep 20204:35 pmRNSPrice Monitoring Extension
24th Sep 20207:00 amRNSUpdate on Phasefocus Holdings Limited
18th Sep 20207:00 amRNSUpdate on the Pharm2Farm anti-viral mask project
8th Sep 202012:18 pmRNSResult of AGM
3rd Sep 20207:00 amRNSFurther re Paraytec Limited
28th Aug 20205:00 pmRNSTotal Voting Rights
21st Aug 20205:09 pmRNSConditional Sale of Pharm 2 Farm Limited holding
20th Aug 20201:04 pmRNSHolding(s) in Company
5th Aug 20204:41 pmRNSSecond Price Monitoring Extn
5th Aug 20204:35 pmRNSPrice Monitoring Extension
5th Aug 20207:00 amRNSFurther re Paraytec Limited
4th Aug 20207:00 amRNSFinal Results
23rd Jul 202011:00 amRNSPrice Monitoring Extension
21st Jul 20204:41 pmRNSSecond Price Monitoring Extn
21st Jul 20204:36 pmRNSPrice Monitoring Extension
13th Jul 20207:18 amRNSParticipation in RMS placing
7th Jul 20207:00 amRNSFurther re Paraytec Limited
1st Jul 20202:31 pmRNSHolding(s) in Company
30th Jun 20205:00 pmRNSTotal Voting Rights
30th Jun 20203:00 pmRNSAcquisition of 18.1% interest in RMS
19th Jun 20202:29 pmRNSOperational Update
9th Jun 20207:00 amRNSFurther re Paraytec Limited
8th Jun 20207:00 amRNSHolding(s) in Company
5th Jun 202012:44 pmRNSDirector/PDMR Shareholding
5th Jun 20207:00 amRNSAcquisition of Additional PhaseFocus Shares
3rd Jun 20209:05 amRNSSecond Price Monitoring Extn
3rd Jun 20209:00 amRNSPrice Monitoring Extension
3rd Jun 20207:00 amRNSDirector/PDMR Shareholding
2nd Jun 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.